Phase Ib/II trial of TG4001 (Tipapkinogene sovacivec), a therapeutic HPV-vaccine, and Avelumab in patients with recurrent/metastatic HPV16 positive cancersChristophe Le Tourneau et al.ESMO 2019Download the poster herePoster Presentation